Based on the specific genetic profile of estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor-2 (Her2), BC patients can be classified into four categories: Luminal A, Luminal B, HER2-positive, and triple-negative subtypes 13, 14. This evidence concerns the gene ESR1 and breast cancer.